Cargando…
1088. Evaluating the Effect of Donepezil on Mortality Among Alzheimer’s Disease Patients With and Without COVID-19 Infection
BACKGROUND: Dementia has been identified as an independent risk factor for increased severity of COVID-19 infection. Donepezil, a cholinesterase inhibitor approved for Alzheimer’s disease (AD), has anti-inflammatory properties. Previous studies have found that donepezil reduced all-cause mortality f...
Autores principales: | Bej, Taissa A, Edmiston, Elizabeth, Wilson, Brigid, Phillips, Joy, Jump, Robin L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751820/ http://dx.doi.org/10.1093/ofid/ofac492.928 |
Ejemplares similares
-
Donepezil-associated survival benefits among Alzheimer’s disease patients are retained but not enhanced during COVID-19 infections
por: Edmiston, Elizabeth A., et al.
Publicado: (2023) -
325. Invasive and Non-Invasive Osteomyelitis Caused by Group B Streptococcus Infection Among Veterans
por: Bej, Taissa A, et al.
Publicado: (2020) -
235. In outpatient clinics serving Veterans, antibiotic prescriptions precede a minority of antibiotic-associated adverse events
por: Wilson, Brigid, et al.
Publicado: (2020) -
2951. Nursing home clinician characteristics associated with simulated urinary tract infection treatment decision-making
por: Taylor, Lindsay, et al.
Publicado: (2023) -
Change to hospitalist providers had a minimal influence on overall antibiotic use in a VA long-term care setting
por: Bej, Taissa, et al.
Publicado: (2023)